Billionaire Profile
Sergio Stevanato & family
Global Rank
#1100

Image: Unsplash Contributor | Unsplash License | via Unsplash

Sergio Stevanato & family

CEO, Medical packaging
ITALY
Real-Time Net Worth
$3.93B
Estimated based on Medical packaging stock value as of April 20, 2026
0% (24h)
Age
83
Source
Medical packaging
Industry
Healthcare
Citizenship
ITALY

Biography

Sergio Stevanato, born in Venice, Italy, in 1943, is the chairman emeritus of the Stevanato Group, a leading medical packaging firm. With a law degree from the University of Ferrara, Stevanato transformed his father's glass manufacturing company, founded in 1949, into a global leader in medical packaging and drug delivery solutions. The Stevanato Group is the second-largest maker of glass vials in the world, playing a crucial role in the distribution of vaccines, including those for COVID-19. Stevanato's career is marked by significant achievements, including being appointed a Cavaliere del Lavoro in 2007, an honor recognizing his contributions to industry and entrepreneurship. As of March 25, 2026, the Stevanato family has a net worth of $3.7 billion.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Sergio Stevanato was born on March 20, 1943, in Venice, Italy. He came from a family with a strong entrepreneurial background; his father, Giovanni Stevanato, founded Soffieria Stella, a glass manufacturing company, in 1949. Growing up, Sergio developed an interest in the glass industry, spending his summers working in the family business.

Rise to Success

After graduating with a law degree from the University of Ferrara in 1969, Sergio Stevanato took over the leadership of the Stevanato Group. Under his guidance, the company evolved from a producer of glass bottles for wine and perfume into a global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical and biotechnology industries. He spearheaded the expansion of the company, establishing a significant presence in the medical packaging sector, including becoming the second-largest producer of glass vials globally. The company's pivotal role in providing vials for COVID-19 vaccines further highlighted its impact.

Key Business Strategies

Stevanato's leadership emphasized technical excellence, quality, and global scale, achieved through strategic plant expansions in Italy, the U.S., Mexico, and Asia. The company focused on integrating its services, moving from basic vials to ready-to-use formats, cartridges, and pre-fillable syringes. This approach strengthened its position in the market, securing significant partnerships with major pharmaceutical companies. The company went public on the New York Stock Exchange (NYSE) in 2021, further solidifying its global presence.

Philanthropy

While specific amounts are not readily available, Sergio Stevanato is known for his passion for philanthropy and has supported various charitable causes and initiatives.

Career Milestones

1949

Founded Soffieria Stella

Giovanni Stevanato founded a glass bottle manufacturing company in Venice, Italy, which later became Stevanato Group

1969

Graduated with Law Degree

Sergio Stevanato graduated with a law degree from the University of Ferrara

1969

Took over Leadership of Stevanato Group

Sergio Stevanato took over the leadership of Stevanato Group, the family business

2007

Appointed Cavaliere del Lavoro

Sergio Stevanato was appointed Cavaliere del Lavoro (Knight of Labor) by the President of the Italian Republic

2021

Stevanato Group IPO

Stevanato Group went public on the New York Stock Exchange

Philanthropy & Social Impact

Philanthropy

Various Charitable Causes

Undisclosed

Supports various charitable causes and initiatives

Business Philosophy & Leadership

Leadership Principles

Technical excellence and quality

Emphasis on quality and technical expertise in sterile injectable packaging

Global scale

Strategic plant expansions to ensure geographic redundancy and proximity to key customers

Integration

Moving up the value chain to offer comprehensive solutions including vials, ready-to-use formats, cartridges, and prefillable syringes